Epigenetic lesions at cell cycle regulators and tumor suppressor genes such as the silencing of cyclin-dependent kinase inhibitor 2A (CDKN2A) locus are frequently found in patients with HCC (11–14). Here, CDKN2A is linked to hepatocellular carcinoma.